Vertex Pharmaceuticals Incorporated (ETR:VX1)

Vertex Pharmaceuticals Revenue

In the year 2024, Vertex Pharmaceuticals had annual revenue of $11.02B USD with 11.66% growth. Vertex Pharmaceuticals had revenue of $2.91B in the quarter ending December 31, 2024, with 15.66% growth.

• Revenue: $11.02B
• Revenue Growth: +11.66%
• P/S Ratio: 10.46
• Revenue / Employee: $1.81M
• Employees: 6,100
• Market Cap: 111.36B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.02B	1.15B	11.66%
Dec 31, 2023	9.87B	938.50M	10.51%
Dec 31, 2022	8.93B	1.36B	17.91%
Dec 31, 2021	7.57B	1.37B	22.06%
Dec 31, 2020	6.21B	2.04B	49.08%